Divi's Laboratories Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DIVISLAB.BO | IPCALAB.NS | LAURUSLABS.NS | RDY | AARTIDRUGS.BO | IOLCP.NS | |
|---|---|---|---|---|---|---|
| Market cap | 2.69T | 494.62B | 1.27T | 12.30B | 40.55B | 55.50B |
| P/E (TTM) | 92.1 | 37.8 | 94.7 | 41.0 | 21.2 | 27.3 |
| Forward P/E | 67.0 | 27.7 | 66.2 | 22.3 | 15.9 | 17.5 |
| Price/book | 16.1 | 6.1 | 20.9 | 18.0 | 2.6 | 2.9 |
| Dividend yield | 0.30% | 0.30% | 0.09% | 0.56% | 0.43% | 0.54% |
| 1-year change | +45.65% | +51.13% | +137.17% | +6.72% | −4.81% | +87.93% |
| Today | +1.14% | −1.14% | +0.96% | +3.29% | −2.23% | +2.89% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All DIVISLAB.BO news ›TVS Motor, Divi's Laboratories, Contenders for Nifty Inclusion
Index rejig Our Bureau Mumbai: Divi's Laboratories and TVS Motor Company could be contenders for inclusion in the Nifty in the NSE's March 2027 index review. These stocks could potentially replace Max Healthcare Institute and HDFC Life,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.